Alessandro Volpe

Partecipa al #UroOncoGUHotTopicsUpdate il 24-25 settembre presso l’Ospedale Maggiore di Novara @UniAvogadro. Letture e discussione interattiva di casi clinici sui tumori genito-urinari. Una top faculty multidisciplinare per discutere gli argomenti piu attuali e controversi in GU Oncology! Iscrizione gratuita a iscrizioni@eureka.it #KidneyCancer #ProstateCancer #BladderCancer

Pleased and honored to give the @Uroweb talk at the @UroOnc annual meeting in Phoenix!

Excited to give this talk on #activesurveillance of #KidneyCancer because I have been a SUO fellow 20 years ago and it is like closing a nice circle for me 😃

Thanks to Dr. Lin and Dr. Kibel for having me and for the warm hospitality!

Thanks @MichaelASJewett and all my mentors at @UofT for the profondi impact they had on my life and my career!

Please join us tomorrow Nov 27 at 17:00-18:15 for the robotic semilive surgery presentation on the latest developments in reconstructive #surgery for #ureteral strictures. Pleased to present my combined #robotic and #endoscopic approach with the moderation of @amerseburger

us02web.zoom.us/webinar/regist…

Very pleased to co-chair with @bkonety a nice and interactive joint session of @Uroweb Oncology Section and @UroOnc #SIU2025Edinburgh on #KidneyCancer and #BladderCancer. Looking forward to an increasingly strong collaboration between pur societies! @AStenzl

We validated the newly proposed cT1 TNM classification of #KIdneyCancer. Renal tumors >3 cm (new cT1b) have a faster growth rate and a higher progression rate than smalller ones. Active surveillance should be cautiously proposed in these cases unless a percutaneous biopsy is performed to rule out high-grade histology @CPalumbo87 @MicNicolazzini @UniAvogadro
kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…